Skip to content

Innate Immunotherapeutics Limited

Proposed ASX code: IIL

Proposed listing date: 23 December 2013 1:00PM EDST ##

Company contact details www.innateimmuno.com
Ph: 61 2 8003 3650
Fax: TBA
Principal Activities Development of a drug to treat secondary progressive multiple sclerosis
GICS industry group Not yet allocated
Issue Price 20 cents per ordinary share
Issue Type Equity
Security code IIL
Capital to be Raised $10,000,000
Expected offer close date 11 December 2013
Underwriter N/A

# Listings dates are proposed dates for first quotation of securities set out in the entity's prospectus or information memorandum. You may not rely on this information in any way.
## Listing dates are anticipated dates for first quotation of securities set by ASX following completion of admission procedures. However, they are subject to change without notice and you may not rely on this information in any way.